Targeting specific cell types with silencing RNA.
Williams
Bryan R
BR
Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, USA.
D000818:Animals; D016503:Drug Delivery Systems; D020868:Gene Silencing; D019302:HIV Envelope Protein gp160; D015497:HIV-1; D006801:Humans; D008546:Melanoma, Experimental / Q000628:therapy; D051379:Mice; D011479:Protamines; D034741:RNA, Small Interfering / Q000008:administration & dosage*; D011956:Receptors, Cell Surface / Q000502:physiology*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage
D019302:HIV Envelope Protein gp160; D011479:Protamines; D034741:RNA, Small Interfering; D011956:Receptors, Cell Surface; D011993:Recombinant Fusion Proteins